Stock listing
Peptidream Inc.
Selected listing: 4587N · BMV · MXN · MX
Peptidream Inc. (BMV:4587N), Health Technology. Latest release Aug 12, 2026: Consolidated Financial Results for the Six Months Ended June 30, 2026 [IFRS].
- Ticker
- BMV:4587/N
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BMV
- Currency
- MXN
Latest news from Peptidream Inc.
Consolidated Financial Results for the Six Months Ended June 30, 2026 [IFRS]
August 12, 2026
Initiation of Phase 1 Clinical Trial by Novartis Marks Milestone for PeptiDream
August 11, 2026
PeptiDream Strengthens Leadership Team with Multiple Key Executive Appointments
July 2, 2026
PeptiDream Announces First Dosing of Claudin18.2 Targeting Radiopharmaceutical Candidate 64Cu-PD-29875 in Patients with Gastric Cancer
June 11, 2026
PeptiDream, PDRadiopharma and Curium Group Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
June 11, 2026
Research Peptidream Inc.
Alternate listings
4587:TSE
JP · JPY
Alternate listing for Peptidream Inc.; the primary context on this page is 4587N:BMV.
PPTDF:OTC
US · USD
Alternate listing for Peptidream Inc.; the primary context on this page is 4587N:BMV.
4587N:BIVA
MX · MXN
Alternate listing for Peptidream Inc.; the primary context on this page is 4587N:BMV.